Northwest Biotherapeutics reported $16.28M in Operating Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Agenus AGEN:US USD 64.42M 1.07M
Applied Genetic Technologies AGTC:US USD 17.34M 705K
AstraZeneca AZN:LN USD 9.74B 495M
Bristol Myers Squibb BMY:US USD 8.75B 552M
Celldex Therapeutics CLDX:US USD 28.1M 8.46M
Cti Biopharma CTIC:US USD 30.46M 753K
Cytori Therapeutics CYTX:US USD 5.17M 47K
Cytrx CYTR:US USD 1.29M 7.73M
Eisai 4523:JP JPY 176.54B 283M
Genocea Biosciences GNCA:US USD 16.04M 2.63M
Infinity Pharmaceuticals INFI:US USD 11.59M 1.11M
Merk MRK:US USD 10.97B 1.31B
Mirati Therapeutics MRTX:US USD 191.87M 9.31M
Northwest Biotherapeutics NWBO:US USD 16.28M 5.41M
Pfizer PFE:US USD 13.23B 2.41B